Compound Detail
CHEMBL4213644
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@]2(C)[C@@]34CC[C@H]5C(C)(C)/C(=N/O)CC[C@]5(C)[C@]3(CC[C@]12C)O4
Basic Information
| ChEMBL ID | CHEMBL4213644 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PJEIETCQWXJNMU-NRMDTAESSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
473.7
MW (Da)
7.35
ALogP
4
HBA
2
HBD
65.3
PSA (Ų)
0.25
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30153006 | 10.1021/acs.jmedchem.8b00705 | Alpha-crystallin A chain | 10 |
| 30153006 | 10.1021/acs.jmedchem.8b00705 | Alpha-crystallin B chain | 9 |
| 30153006 | 10.1021/acs.jmedchem.8b00705 | Beta-crystallin B2 | 6 |
| 30153006 | 10.1021/acs.jmedchem.8b00705 | Gamma-crystallin C | 6 |
| 30153006 | 10.1021/acs.jmedchem.8b00705 | Gamma-crystallin D | 6 |
Data from ChEMBL 36 via Core Engine